DK0760867T3 - Kompositioner og metoder der ralaterer til DNA mismatch repair-gener - Google Patents

Kompositioner og metoder der ralaterer til DNA mismatch repair-gener

Info

Publication number
DK0760867T3
DK0760867T3 DK95906061T DK95906061T DK0760867T3 DK 0760867 T3 DK0760867 T3 DK 0760867T3 DK 95906061 T DK95906061 T DK 95906061T DK 95906061 T DK95906061 T DK 95906061T DK 0760867 T3 DK0760867 T3 DK 0760867T3
Authority
DK
Denmark
Prior art keywords
methods
compositions
genes
mismatch repair
methods related
Prior art date
Application number
DK95906061T
Other languages
Danish (da)
English (en)
Inventor
C Eric Bronner
Sean M Baker
Roni J Bollag
Richard D Kolodner
Robert M Liskay
Original Assignee
Univ Oregon Health Sciences
Dana Farber Cancer Inst Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/209,521 external-priority patent/US5922855A/en
Application filed by Univ Oregon Health Sciences, Dana Farber Cancer Inst Inc filed Critical Univ Oregon Health Sciences
Application granted granted Critical
Publication of DK0760867T3 publication Critical patent/DK0760867T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/16Primer sets for multiplex assays

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Hospice & Palliative Care (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
DK95906061T 1993-12-17 1994-12-16 Kompositioner og metoder der ralaterer til DNA mismatch repair-gener DK0760867T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16887793A 1993-12-17 1993-12-17
US08/209,521 US5922855A (en) 1993-12-17 1994-03-08 Mammalian DNA mismatch repair genes MLH1 and PMS1
US08/352,902 US6191268B1 (en) 1993-12-17 1994-12-09 Compositions and methods relating to DNA mismatch repair genes

Publications (1)

Publication Number Publication Date
DK0760867T3 true DK0760867T3 (da) 2006-10-23

Family

ID=27389577

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95906061T DK0760867T3 (da) 1993-12-17 1994-12-16 Kompositioner og metoder der ralaterer til DNA mismatch repair-gener

Country Status (10)

Country Link
US (4) US6191268B1 (de)
EP (1) EP0760867B1 (de)
JP (1) JP4101285B2 (de)
AT (1) ATE330009T1 (de)
AU (1) AU1442495A (de)
CA (1) CA2179285A1 (de)
DE (1) DE69434765T2 (de)
DK (1) DK0760867T3 (de)
ES (1) ES2270424T3 (de)
WO (1) WO1995016793A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6191268B1 (en) * 1993-12-17 2001-02-20 Dana-Farber Cancer Institute Compositions and methods relating to DNA mismatch repair genes
US6482606B1 (en) * 1994-01-27 2002-11-19 Human Genome Sciences, Inc. Human DNA mismatch repair polynucleotides
CA2182206A1 (en) * 1994-01-27 1995-08-03 William A. Haseltine Human dna mismatch repair proteins
US6380369B1 (en) * 1994-01-27 2002-04-30 Human Genome Sciences, Inc. Human DNA mismatch repair proteins
AUPM612494A0 (en) * 1994-06-08 1994-06-30 Csl Limited Treatment or prevention of helicobacter infection
JPH0847247A (ja) * 1994-08-05 1996-02-16 Fuji Denki Kogyo Kk Dc/dcコンバータ回路
CA2223971A1 (en) * 1995-06-07 1996-12-19 Marilee Burrell Antibody detection of mismatch repair proteins
US6294325B1 (en) 1996-07-05 2001-09-25 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of thermostable multi genes and proteins and uses thereof
WO1999001550A1 (en) * 1997-07-03 1999-01-14 Dana-Farber Cancer Institute A method for detection of alterations in msh5
DE19739611A1 (de) * 1997-09-09 1999-03-11 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Nucleinsäure-Sequenzen und Verfahren zum Nachweis von Bakterien der Gattung Pseudomonas
DE19747748A1 (de) * 1997-10-29 1999-05-06 Manfred Dr Dr Gross Testverfahren zur Identifizierung von Personen mit defektem Mismatch-Reparatursystem
US6146894A (en) * 1998-04-14 2000-11-14 The Johns Hopkins University Method for generating hypermutable organisms
US7148016B1 (en) 1999-01-14 2006-12-12 Ca*Tx Inc. Immunoassays to detect diseases or disease susceptibility traits
ATE404665T1 (de) * 2000-02-11 2008-08-15 Univ Johns Hopkins Methode zur herstellung hypermutierender bakterien
DE60039371D1 (de) * 2000-02-18 2008-08-14 Morphotek Inc Methode zur herstellung hypermutabler pflanzen
WO2001062945A1 (en) * 2000-02-23 2001-08-30 The Johns Hopkins University Methods for generating hypermutable yeast
US6677146B1 (en) * 2000-03-28 2004-01-13 Replidyne, Inc. Thermophilic polymerase III holoenzyme
US6825038B2 (en) * 2000-05-12 2004-11-30 The Johns Hopkins University Method for generating hypermutable organisms
EP1364008A2 (de) * 2000-07-27 2003-11-26 University Of Delaware Verfahren zur verbesserung gezielter genmanipulationen mit hilfe von oligonukleotiden
US6808894B1 (en) * 2000-11-07 2004-10-26 Morphotek, Inc. Methods for generating genetically altered antibody producing cell lines with improved antibody characteristics
US6576468B1 (en) * 2000-11-07 2003-06-10 Morphotek, Inc. Methods for obtaining microbe-resistant mammalian cells from hypermutable mammalian cells
US7223598B2 (en) * 2000-11-07 2007-05-29 Morphotek, Inc. Methods for isolating novel antimicrobial agents from hypermutable mammalian cells
US7235643B2 (en) * 2000-11-07 2007-06-26 Morphotek, Inc. Antibodies and methods for generating genetically altered antibodies with high affinity
US6737268B1 (en) * 2000-11-14 2004-05-18 Morphotek, Inc. Method for generating genetically altered antigens
EP1351565B1 (de) * 2001-01-15 2011-03-16 Morphotek, Inc. Chemische hemmstoffe des mismatch-repair
US6982169B2 (en) 2001-01-15 2006-01-03 Morphotek, Inc. Chemical inhibitors of mismatch repair
US20030068808A1 (en) * 2001-07-25 2003-04-10 Nicolaides Nicholas C. Methods for generating antibiotic resistant microbes and novel antibiotics
US20030165940A1 (en) * 2001-12-06 2003-09-04 The Johns Hopkins University Disease detection by digital protein truncation assays
EP1551988B1 (de) * 2002-07-19 2010-11-24 Morphotek, Inc. VERFAHREN ZUR ERZEUGUNG VERBESSERTER ANTIKöRPER PRODUZIERENDER ZELLINIEN MIT VERBESSERTEN WACHSTUMSEIGENSCHAFTEN
US7316903B2 (en) * 2003-03-28 2008-01-08 United States Of America As Represented By The Department Of Health And Human Services Detection of nucleic acid sequence variations using phase Mu transposase
JP2007537709A (ja) * 2003-05-23 2007-12-27 モーフオテク・インコーポレーテツド 腫瘍抗原を特異的に結合するモノクローナル抗体
CA2548813A1 (en) * 2003-12-08 2005-06-23 Morphotek, Inc. Antibodies that specifically bind pms2
JP4805848B2 (ja) * 2004-02-12 2011-11-02 モルフォテック、インク. 腫瘍抗原の生物活性を特異的に阻止するモノクローナル抗体
EP2322560B1 (de) * 2005-03-10 2013-09-04 Morphotek, Inc. Anti-Mesothelin-Antikörper
EP1879922A2 (de) 2005-04-22 2008-01-23 Morphotek, Inc. Antikörper mit immuneffektoraktivität, die in alpha-positive folatrezeptorzellen internalisiert werden
CN102296105A (zh) * 2010-06-25 2011-12-28 复旦大学 一种检测mlh1基因突变的方法及其试剂盒
WO2019041045A1 (en) 2017-09-01 2019-03-07 The Hospital For Sick Children PROFILING AND TREATMENT OF HYPERMUTANT CANCER

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US5043272A (en) * 1989-04-27 1991-08-27 Life Technologies, Incorporated Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers
WO1993022457A1 (en) * 1992-04-24 1993-11-11 Massachusetts Institute Of Technology Screening for genetic variation
US7229755B1 (en) * 1993-11-17 2007-06-12 Dana Farber Cancer Institute, Inc. Method for detection of alterations in the DNA mismatch repair pathway
ATE273387T1 (de) * 1993-12-02 2004-08-15 Univ Johns Hopkins Menschliches mutator-gen nmsh2 und seine verbindung zum hereditaren, nichtpolypösen kolorrektalen karzinom
US6191268B1 (en) * 1993-12-17 2001-02-20 Dana-Farber Cancer Institute Compositions and methods relating to DNA mismatch repair genes
CA2182206A1 (en) * 1994-01-27 1995-08-03 William A. Haseltine Human dna mismatch repair proteins

Also Published As

Publication number Publication date
US20030224463A1 (en) 2003-12-04
EP0760867B1 (de) 2006-06-14
AU1442495A (en) 1995-07-03
CA2179285A1 (en) 1995-06-22
EP0760867A1 (de) 1997-03-12
US6538108B1 (en) 2003-03-25
WO1995016793A1 (en) 1995-06-22
ATE330009T1 (de) 2006-07-15
EP0760867A4 (de) 1998-11-25
US6165713A (en) 2000-12-26
DE69434765T2 (de) 2007-05-24
ES2270424T3 (es) 2007-04-01
JPH09512702A (ja) 1997-12-22
DE69434765D1 (de) 2006-07-27
JP4101285B2 (ja) 2008-06-18
US6191268B1 (en) 2001-02-20

Similar Documents

Publication Publication Date Title
DK0760867T3 (da) Kompositioner og metoder der ralaterer til DNA mismatch repair-gener
Nagamine et al. A PCR artifact: generation of heteroduplexes.
Mironov et al. Alterations of (CA) n DNA repeats and tumor suppressor genes in human gastric cancer
Schilling et al. Allele-specific DNA methylation in mouse strains is mainly determined by cis-acting sequences
Agarwal et al. DNA double-strand break repair and chromosome translocations
Bois et al. Minisatellite instability and germline mutation
Parsons et al. Mismatch repair deficiency in phenotypically normal human cells
Stoneking et al. Human evolution and the mitochondrial genome
Modrich Mismatch repair, genetic stability, and cancer
Ricchetti et al. Continued colonization of the human genome by mitochondrial DNA
Hallast et al. Recombination dynamics of a human Y-chromosomal palindrome: rapid GC-biased gene conversion, multi-kilobase conversion tracts, and rare inversions
NO970624D0 (no) In vivo mutasjoner og polymorfismer i 17q-koblete bryst-og ovariekreft mottagelighetsgener
NO961165L (no) Fremgangsmåte og kit for effektiv sekvensering av nukleinsyre
WO1999029903A3 (en) Cancer susceptibility mutations of brca1
Currier et al. Spectratype/immunoscope analysis of the expressed TCR repertoire
Dunleavey et al. Rapid genotype analysis of the matrix metalloproteinase-1 gene 1G/2G polymorphism that is associated with risk of cancer
Yong et al. Chromosome 19q deletions in human gliomas overlap telomeric to D19S219 and may target a 425 kb region centromeric to D19S112
Darst et al. DNA methyltransferase accessibility protocol for individual templates by deep sequencing
Svensson et al. Coat colour and sex identification in horses from Iron Age Sweden
Demars et al. Genetic variants within the second intron of the KCNQ1 gene affect CTCF binding and confer a risk of Beckwith–Wiedemann syndrome upon maternal transmission
Okamura et al. Whole-exome sequencing of fibroblast and its iPS cell lines derived from a patient diagnosed with xeroderma pigmentosum
Szantai et al. Genotyping and haplotyping of the dopamine D4 receptor gene by capillary electrophoresis
Wilson et al. Human globin messenger RNA: importance of cloning for structural analysis
Andrade et al. Associations of OCA2-HERC2 SNPs and haplotypes with human pigmentation characteristics in the Brazilian population
Smith-Sørensen et al. Screening for mutations in human HPRT cDNA using the polymerase chain reaction (PCR) in combination with constant denaturant gel electrophoresis (CDGE)